Corning® Ascent® FBR - Innovative technology for scalable adherent cell culture

Advances in the science of gene and cell therapies have created rapid growth in the industry, with the common challenge of producing therapeutic cells or viruses at manufacturing scale. Corning has developed a novel fixed bed bioreactor system to address the need for more efficient solutions for cell and gene therapies as well as vaccine production. In this webinar you will learn how the Corning Ascent FBR System enables high yields of cells and viral vectors through its unique fixed bed design. Further, we will cover how efficient cell-harvest, automation, process control and ready-to-use consumables will improve your adherent bioproduction.